Julie Bolcaen
Department of Nuclear Medicine
Ghent University Hospital
Julie Bolcaen has not added Biography.
If you are Julie Bolcaen and would like to personalize this page please email our Author Liaison for assistance.
Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study.
Journal of neuroimaging : official journal of the American Society of Neuroimaging Jul, 2013 | Pubmed ID: 23279326
MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).
Journal of neuro-oncology Nov, 2014 | Pubmed ID: 25069566
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Nuclear medicine and biology Jan, 2015 | Pubmed ID: 25218024
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
PloS one , 2016 | Pubmed ID: 27559736
18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria.
Nuclear medicine communications Mar, 2017 | Pubmed ID: 27984537
In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging Dec, 2017 | Pubmed ID: 28303489
Technical feasibility of [F]FET and [F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model.
Radiation oncology (London, England) May, 2019 | Pubmed ID: 31146757
The Impact of Dose Rate on DNA Double-Strand Break Formation and Repair in Human Lymphocytes Exposed to Fast Neutron Irradiation.
International journal of molecular sciences Oct, 2019 | Pubmed ID: 31661782
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
PloS one , 2021 | Pubmed ID: 33667282
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.
Pharmaceuticals (Basel, Switzerland) Jun, 2021 | Pubmed ID: 34209513
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.
Frontiers in oncology , 2021 | Pubmed ID: 34307171
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
Theranostics , 2021 | Pubmed ID: 34335972
DNA damage response of haematopoietic stem and progenitor cells to high-LET neutron irradiation.
Scientific reports Oct, 2021 | Pubmed ID: 34675263
An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes
Shankari Nair1,
Samantha Cairncross2,
Xanthene Miles1,
Monique Engelbrecht3,
Peter du Plessis1,
Julie Bolcaen1,
Randall Fisher1,
Roya Ndimba1,
Charnay Cunningham4,
Wilner Martínez-López5,
Christian Schunck6,
Charlot Vandevoorde1
1Radiation Biophysics Division, Nuclear Medicine Department, iThemba LABS,
2Department of Biotechnology, University of the Western Cape,
3Department of Medical Biosciences, University of the Western Cape,
4Division of Medical Physiology, Department of Medicine and Health Sciences, Stellenbosch University,
5Biodosimetry Service, Instituto de Investigaciones Biológicas Clemente Estable and Academic Unit on Radiation Protection, Faculty of Medicine, University of the Republic,
6, MetaSystems Hard & Software GmbH
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved